← FDA Drug Approvals (Drugs@FDA)

IPRATROPIUM BROMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL · Approved 2022-08-16

Drug application

FDA Application #

ANDA215104

Application type

Abbreviated New Drug Application (Generic)

Brand name

IPRATROPIUM BROMIDE

Generic name

IPRATROPIUM BROMIDE

Active ingredients

IPRATROPIUM BROMIDE

Dosage form

SPRAY, METERED

Route

NASAL

Marketing status

Prescription

Sponsor

AMNEAL

Manufacturer

Amneal Pharmaceuticals NY LLC

First approval

2022-08-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown